These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11931417)

  • 1. Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains.
    Uzun M; Erturan Z; Anğ O
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):164-5. PubMed ID: 11931417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Yamada H; Mitarai S
    Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
    Senol G; Erbaycu A; Ozsöz A
    J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ; Liu YH; Jiang GL; Wang SM; Fu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):192-4. PubMed ID: 15854417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C; Karaca-Derici Y; Bilgic A
    Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge.
    van Ingen J; Aarnoutse R; de Vries G; Boeree MJ; van Soolingen D
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):990-2. PubMed ID: 21682979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of rapid detection for rifampin resistance in clinical isolates of Mycobacterium tuberculosis by phage amplified biologically assay].
    Hu ZY; Jin AJ; Chen HP; Cui ZL; Jing LJ; Wang J; Weng XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):811-4. PubMed ID: 15730778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan.
    Chien HP; Yu MC; Ong TF; Lin TP; Luh KT
    J Formos Med Assoc; 2000 May; 99(5):408-11. PubMed ID: 10870331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
    Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
    J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
    Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis].
    Sato K; Tomioka H; Saito H; Kawahara S; Hidaka T
    Kekkaku; 1996 Aug; 71(8):459-64. PubMed ID: 8831191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
    Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.
    Kisa O; Albay A; Bedir O; Baylan O; Doganci L
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):284-8. PubMed ID: 12661845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory MA
    Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli.
    Luna-Herrera J; Reddy MV; Gangadharam PR
    J Antimicrob Chemother; 1995 Aug; 36(2):355-63. PubMed ID: 8522465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.